These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 534841)

  • 1. Prostatic lymphoscintigraphy.
    Stone AR; Merrick MV; Chisholm GD
    Br J Urol; 1979 Dec; 51(6):556-60. PubMed ID: 534841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved techniques in radionuclide imaging of prostatic lymph nodes.
    Gardiner RA; Fitzpatrick JM; Constable AR; Cranage RW; O'Donoghue EP; Wickham JE
    Br J Urol; 1979 Dec; 51(6):561-4. PubMed ID: 534842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of canine and human prostatic lymph nodes following intraprostatic injection of technetium-99m-antimony sulfide colloid.
    Kaplan WD; Whitmore WF; Gittes RF
    Invest Radiol; 1980; 15(1):34-8. PubMed ID: 7353941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic lymphoscintigraphy. A preliminary report.
    Gardiner RA; Fitzpatrick JM; Constable AR; Cranage RW; O'Donoghue EP; Wickham JE
    Br J Urol; 1979 Aug; 51(4):300-3. PubMed ID: 466007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scintigraphic representation of the regional lymph nodes of the prostate and bladder using a gamma chamber].
    Reuter HJ; Loenicker EM
    Z Urol Nephrol; 1979 Mar; 72(3):185-7. PubMed ID: 463374
    [No Abstract]   [Full Text] [Related]  

  • 6. Technetium-99m antimony sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection.
    Zuckier LS; Finkelstein M; Kreutzer ER; Stone PL; Freed SZ; Bard RH; Blaufox MD; Freeman LM
    Nucl Med Commun; 1990 Sep; 11(9):589-96. PubMed ID: 2234694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.
    Wanebo HJ; Harpole D; Teates CD
    Cancer; 1985 Mar; 55(6):1403-13. PubMed ID: 3971311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoscintigraphy: a comparison of 99Tc(m) antimony sulphide colloid and 99Tc(m) stannous phytate.
    Ege GN; Warbick A
    Br J Radiol; 1979 Feb; 52(614):124-9. PubMed ID: 427362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of lymph node invasion in prostatic carcinoma with iliopelvic lymphoscintigraphy.
    Horenblas S; Nuyten MJ; Hoefnagel CA; Moonen LM; Delemarre JF
    Br J Urol; 1992 Feb; 69(2):180-2. PubMed ID: 1537030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of prostatic lymphoscintigraphy].
    Takeuchi T; Isogai K; Yoshida H; Matsuo S; Yasuda E; Kanamori I; Fujimoto Y; Fujihiro S; Kuriyama M; Nishiura T
    Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1544-9. PubMed ID: 6202920
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative cutaneous lymphoscintigraphy in malignant melanoma.
    Lock-Andersen J; Rossing N; Drzewiecki KT
    Cancer; 1989 Jan; 63(1):77-82. PubMed ID: 2910428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct comparison between subcutaneous and intralymphatic injections for lymphoscintigraphy.
    Gibson CJ; Vijayasimhulu GT; Diffey BL
    Clin Radiol; 1984 Jan; 35(1):81-3. PubMed ID: 6690187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of pelvic lymphoscintigraphy in the staging of colorectal carcinoma.
    Reasbeck PG; Manktelow A; McArthur AM; Packer SG; Berkeley BB
    Br J Surg; 1984 Dec; 71(12):936-40. PubMed ID: 6208965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented iliopelvic lymphoscintigraphy: application in the management of genitourinary malignancy.
    Ege GN
    J Urol; 1982 Feb; 127(2):265-9. PubMed ID: 7062381
    [No Abstract]   [Full Text] [Related]  

  • 15. Iliopelvic lymphoscintigraphy as a predictor of early metastatic disease in patients with prostate carcinoma.
    Ferrier D; Kloiber R
    Clin Nucl Med; 1992 May; 17(5):357-60. PubMed ID: 1587039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid.
    Sullivan DC; Croker BP; Harris CC; Deery P; Seigler HF
    AJR Am J Roentgenol; 1981 Oct; 137(4):847-51. PubMed ID: 6974983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioisotope lymphoscintigraphy used for precise diagnosis of metastatic lymph node involvement in localized and locally advanced prostate cancer].
    Rusakov IG; Alekseev BIa; Niushko KM; Frank GA; Belova EA; Bespalov PD; Vorob'ëv NV; Poliakov VA
    Vopr Onkol; 2006; 52(6):686-90. PubMed ID: 17338250
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
    McLean RG; Ege GN
    J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
    Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
    Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes.
    Scopinaro F; De Vincentis G; Varvarigou AD; Laurenti C; Iori F; Remediani S; Chiarini S; Stella S
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1378-82. PubMed ID: 12920485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.